PL364053A1 - Naphtothiazine positive allosteric ampa receptor modulators (paarm) - Google Patents

Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Info

Publication number
PL364053A1
PL364053A1 PL02364053A PL36405302A PL364053A1 PL 364053 A1 PL364053 A1 PL 364053A1 PL 02364053 A PL02364053 A PL 02364053A PL 36405302 A PL36405302 A PL 36405302A PL 364053 A1 PL364053 A1 PL 364053A1
Authority
PL
Poland
Prior art keywords
paarm
naphtothiazine
receptor modulators
positive allosteric
ampa receptor
Prior art date
Application number
PL02364053A
Other languages
Polish (pl)
Inventor
Angelo Ceci
Klaus Klinder
Thomas Weiser
Karin Winter
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL364053A1 publication Critical patent/PL364053A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PL02364053A 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm) PL364053A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (en) 2001-05-17 2001-05-17 New naphtho-1,2-thiazine compounds, useful as neuroprotectants for treating e.g. epilepsy or Alzheimer's disease, are allosteric modulators of AMPA receptors
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
PL364053A1 true PL364053A1 (en) 2004-12-13

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364053A PL364053A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Country Status (26)

Country Link
EP (1) EP1404340A1 (en)
JP (1) JP2004529980A (en)
KR (1) KR20040007572A (en)
CN (1) CN1533278A (en)
AR (1) AR036332A1 (en)
BG (1) BG108324A (en)
BR (1) BR0209796A (en)
CA (1) CA2449189A1 (en)
CO (1) CO5550460A2 (en)
CZ (1) CZ20033112A3 (en)
DE (1) DE10123952A1 (en)
EA (1) EA006608B1 (en)
EC (1) ECSP034852A (en)
EE (1) EE200300566A (en)
HR (1) HRP20030933A2 (en)
HU (1) HUP0401273A3 (en)
IL (1) IL158642A0 (en)
MX (1) MXPA03010373A (en)
NO (1) NO20035088D0 (en)
NZ (1) NZ530154A (en)
PL (1) PL364053A1 (en)
SK (1) SK14222003A3 (en)
UY (1) UY27290A1 (en)
WO (1) WO2002100411A1 (en)
YU (1) YU90403A (en)
ZA (1) ZA200308466B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010501597A (en) * 2006-08-31 2010-01-21 ザ ガバナーズ オブ ザ ユニバーシティー オブ アルバータ Method for inhibiting respiratory depression using positive allosteric AMPA receptor modulators
CN111518058B (en) * 2020-05-29 2021-03-09 四川大学华西医院 A kind of oxthiazide compound and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US6346526B1 (en) * 1998-06-25 2002-02-12 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
DE10004572A1 (en) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma New positive allosteric AMPA receptor modulators (PAARM), processes for their production and their use as medicines

Also Published As

Publication number Publication date
BR0209796A (en) 2004-06-01
ZA200308466B (en) 2004-05-24
MXPA03010373A (en) 2004-03-16
CA2449189A1 (en) 2002-12-19
KR20040007572A (en) 2004-01-24
CO5550460A2 (en) 2005-08-31
YU90403A (en) 2006-05-25
IL158642A0 (en) 2004-05-12
CN1533278A (en) 2004-09-29
HUP0401273A2 (en) 2004-10-28
CZ20033112A3 (en) 2004-03-17
UY27290A1 (en) 2002-12-31
NO20035088L (en) 2003-11-14
JP2004529980A (en) 2004-09-30
NO20035088D0 (en) 2003-11-14
SK14222003A3 (en) 2004-05-04
BG108324A (en) 2004-12-30
HUP0401273A3 (en) 2006-11-28
AR036332A1 (en) 2004-09-01
DE10123952A1 (en) 2002-11-21
HRP20030933A2 (en) 2004-04-30
EA006608B1 (en) 2006-02-24
ECSP034852A (en) 2003-12-24
WO2002100411A1 (en) 2002-12-19
EE200300566A (en) 2004-02-16
NZ530154A (en) 2005-09-30
EP1404340A1 (en) 2004-04-07
EA200301167A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
IL158038A0 (en) Allosteric adenosine receptor modulators
IL150912A0 (en) Adenosine receptor modulators
GB2384570B (en) Modulators
AU2003245773A1 (en) Vanilloid receptor modulators
AU2003265128A8 (en) Positive allosteric modulators of the nicotinic acetylcholine receptor
IL159594A0 (en) Adenosine a3 receptor modulators
PL375559A1 (en) Calcium receptor modulating agents
GB0129174D0 (en) Havi-upnp bridging
AU2003237492A1 (en) Urotensin ii receptor modulators
AU2002360487A1 (en) Acyclovir-peptide analogs
GB0129177D0 (en) Havi-upnp bridging
GB0123379D0 (en) Modulators
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2002357219A1 (en) Frequency-down-converter using sigma-delta modulators
EP1581309A4 (en) Kinase modulators
IL158642A0 (en) Naphthothiazine positive allosteric ampa receptor modulators (paarm)
GB0102876D0 (en) Triboluminescent devices
GB2388034B (en) Fixing devices for prosthetic devices
HK1064292A (en) Allosteric adenosine receptor modulators
AU2002366012A1 (en) Transferring device
PL370980A1 (en) Benzothiophenes as adenosine receptor modulators
AU2002249304A1 (en) Novel human gnrh receptor
GB0106338D0 (en) Electro-optic modulators
GB0111959D0 (en) Receptor
GB0110662D0 (en) Receptor

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)